Study Examines Delays in Establishing Care in Hispanic Patients with Pancreatic Adenocarcinoma
In patients with pancreatic adenocarcinoma (PDAC), immediate treatment initiation is preferred. A study presented at the 2024 ASCO Annual Meeting evaluated the timing of care initiation in a mainly Hispanic population of PDAC patients. The results found significant delays in establishing care with oncology, palliative care, and hospice, as well as low rates of advanced care planning. The patients also had significantly longer time to treatment initiation and lower rates of genetic testing.